| Year |
Citation |
Score |
| 2024 |
Xie Q, Chen X, Ma H, Zhu Y, Ma Y, Jalinous L, Cox GF, Weaver F, Yang J, Kennedy Z, Gruntman A, Du A, Su Q, He R, Tai PW, et al. Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor. Embo Molecular Medicine. PMID 38413838 DOI: 10.1038/s44321-024-00037-x |
0.356 |
|
| 2021 |
Pan X, Yue Y, Boftsi M, Wasala LP, Tran NT, Zhang K, Pintel DJ, Tai PWL, Duan D. Rational engineering of a functional CpG-free ITR for AAV gene therapy. Gene Therapy. PMID 34611321 DOI: 10.1038/s41434-021-00296-0 |
0.385 |
|
| 2021 |
Muhuri M, Zhan W, Maeda Y, Li J, Lotun A, Chen J, Sylvia K, Dasgupta I, Arjomandnejad M, Nixon T, Keeler AM, Manokaran S, He R, Su Q, Tai PWL, et al. Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction. Frontiers in Immunology. 12: 674242. PMID 33995418 DOI: 10.3389/fimmu.2021.674242 |
0.319 |
|
| 2019 |
Xiao Y, Muhuri M, Li S, Qin W, Xu G, Luo L, Li J, Letizia AJ, Wang SK, Chan YK, Wang C, Fuchs SP, Wang D, Su Q, Nahid MA, ... ... Tai PW, et al. Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity. Jci Insight. 5. PMID 31112525 DOI: 10.1172/Jci.Insight.99052 |
0.362 |
|
| 2012 |
Tai PW, Smith CL, Angello JC, Hauschka SD. Analysis of fiber-type differences in reporter gene expression of β-gal transgenic muscle. Methods in Molecular Biology (Clifton, N.J.). 798: 445-59. PMID 22130853 DOI: 10.1007/978-1-61779-343-1_26 |
0.772 |
|
| 2012 |
Himeda CL, Tai PW, Hauschka SD. Analysis of muscle gene transcription in cultured skeletal muscle cells. Methods in Molecular Biology (Clifton, N.J.). 798: 425-43. PMID 22130852 DOI: 10.1007/978-1-61779-343-1_25 |
0.782 |
|
| 2011 |
Tai PW, Fisher-Aylor KI, Himeda CL, Smith CL, Mackenzie AP, Helterline DL, Angello JC, Welikson RE, Wold BJ, Hauschka SD. Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancer. Skeletal Muscle. 1: 25. PMID 21797989 DOI: 10.1186/2044-5040-1-25 |
0.763 |
|
| 2007 |
Salva MZ, Himeda CL, Tai PW, Nishiuchi E, Gregorevic P, Allen JM, Finn EE, Nguyen QG, Blankinship MJ, Meuse L, Chamberlain JS, Hauschka SD. Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 320-9. PMID 17235310 DOI: 10.1038/Sj.Mt.6300027 |
0.699 |
|
| 2006 |
Salva MZ, Himeda CL, Tai P, Nishiuchi E, Finn EE, Allen JM, Gregorevic P, Blankinship MJ, Meuse LA, Chamberlain JS, Hauschka SD. 561. Novel Tissue-Specific Regulatory Cassettes Direct High-Level Transgene Expression in Skeletal and Cardiac Muscle Molecular Therapy. 13: S216. DOI: 10.1016/J.Ymthe.2006.08.634 |
0.69 |
|
| 2005 |
Salva MZ, Himeda CL, Tai P, Blankinship MJ, Gregorevic P, Allen JM, Meuse LA, Chamberlain JS, Hauschka SD. 266. Development of rAAV-Based Skeletal and Cardiac Muscle Regulatory Cassettes for Gene Therapy of Duchenne Muscular Dystrophy Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.269 |
0.713 |
|
| Show low-probability matches. |